Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage

被引：24

作者：

Campanati, Anna ^{[1
]}

Martina, Emanuela ^{[1
]}

Giuliodori, Katia ^{[1
]}

Bobyr, Ivan ^{[1
]}

Consales, Veronica ^{[1
]}

Offidani, Annamaria ^{[1
]}

机构：

[1] Polytech Marche Univ, Dept Clin & Mol Sci, Dermatol Unit, I-60127 Ancona, Italy

来源：

DERMATOLOGIC THERAPY | 2019年 / 32卷 / 03期

关键词：

apocrine gland; botulinum toxin a; fold dermatitis; Hidradenitis suppurativa; PATHOGENESIS; DISEASE;

D O I：

10.1111/dth.12841

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Hidradenitis suppurativa is a chronic skin disease with an intense inflammatory activation. It typically affects the intertriginous areas with cysts, fistulae, and scarring extremely painful. Patients suffer from severe psychological impact. HS still results in a high unmet medical need with several underdiagnosed cases, probably due to the incomplete knowledge of the pathogenesis of HS. The use of botulinum toxin a has recently been proposed as an effective therapy for HS.

引用

页数：3

共 17 条

[1] Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach [J].

Campanati, A. ;

Giuliodori, K. ;

Giuliano, A. ;

Martina, E. ;

Ganzetti, G. ;

Marconi, B. ;

Chiarici, A. ;

Offidani, A. .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2013, 305 (08) :691-697

[2]

Campanati A, 2017, SKIN APPENDAGE DISOR, V3, P39, DOI 10.1159/000452341

[3] Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel [J].

Campanati, Anna ;

Martina, Emanuela ;

Giuliodori, Katia ;

Ganzetti, Giulia ;

Marconi, Barbara ;

Conte, Irene ;

Giangiacomi, Mirella ;

Offidani, Annamaria .

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2014, 23 (02) :39-41

[4] Hidradenitis suppurrativa (acne inversa) as a systemic disease [J].

Dessinioti, Clio ;

Katsambas, Andreas ;

Antoniou, Christina .

CLINICS IN DERMATOLOGY, 2014, 32 (03) :397-408

[5]

Emanuela M, 2017, ACTA DERMATOVEN ALP, V26, P21, DOI 10.15570/actaapa.2017.6

[6] Prepubertal Hidradenitis Suppurativa Successfully Treated with Botulinum Toxin A [J].

Feito-Rodriguez, Marta ;

Sendagorta-Cudos, Elena ;

Herranz-Pinto, Pedro ;

de Lucas-Laguna, Raul .

DERMATOLOGIC SURGERY, 2009, 35 (08) :1300-1302

[7] A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa [J].

Frew, J. W. ;

Vekic, D. A. ;

Woods, J. ;

Cains, G. D. .

BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) :987-998

[8] Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop [J].

Hessam, S. ;

Sand, M. ;

Gambichler, T. ;

Skrygan, M. ;

Rueddel, I. ;

Bechara, F. G. .

BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (03) :761-767

[9] Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions [J].

Hessam, Schapoor ;

Sand, Michael ;

Georgas, Dimitrios ;

Anders, Agnes ;

Bechara, Falk G. .

SKIN PHARMACOLOGY AND PHYSIOLOGY, 2016, 29 (03) :161-167

[10] Hidradenitis suppurativa: the role of immune dysregulation [J].

Kelly, Genevieve ;

Sweeney, Cheryl M. ;

Tobin, Anne-Marie ;

Kirby, Brian .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (10) :1186-1196

← 1 2 →